|
DEVELOPING ALTERNATIVE APPROACHES TO REDUCE RETINAL TOXICITY AND PREVENT VISION LOSS IN THE TREATMENT OF INTRAOCULAR RETINOBLASTOMA |
1K08EY027464-01 |
DANIELS, ANTHONY BRENT |
NEI |
2017 |
|
ADDRESSING LOW VISION DUE TO SEVERE PERIPHERAL FIELD LOSS: DEVELOPMENT AND VALIDATION OF A PATIENT-CENTERED OUTCOME MEASURE |
1K23EY027848-01 |
EHRLICH, JOSHUA ROBERT |
NEI |
2017 |
|
VISION DEFECTS ASSOCIATED WITH LOSS OF C-VPS FUNCTION |
1R01EY026551-01A1 |
THUMMEL, RYAN |
NEI |
2017 |
|
OPTIMAL MAGNIFICATION AND OCULOMOTOR STRATEGIES IN LOW VISION PATIENTS |
1R01EY026617-01A1 |
MASSOF, ROBERT W. |
NEI |
2017 |
|
PATHOGENIC B CELL AND T HELPER CELL INTERACTIONS IN NEUROMYELITIS OPTICA |
1R01EY027346-01 |
AXTELL, ROBERT C |
NEI |
2017 |
|
INTRAVENOUS MITOTARGETED AAV9 GENE THERAPY FOR TREATMENT OF VISUAL LOSS AND ENCEPHALOPATHY IN LEIGH SYNDROME AND NARP |
1R01EY027414-01 |
GUY, JOHN |
NEI |
2017 |
|
RAPALOG THERAPY IN HERITABLE AND VIGABATRIN-INDUCED GABA METABOLIC DISORDERS |
1R01EY027476-01 |
GIBSON, K MICHAEL |
NEI |
2017 |
|
PHOTOVOLTAIC SUBRETINAL PROSTHESIS WITH HIGH PIXEL DENSITY |
1R01EY027786-01 |
PALANKER, DANIEL V |
NEI |
2017 |
|
BENEFIT ASSESSMENT TOOLS FOR SUBSTITUTE PROSTHETIC REGENERATIVE AND ULTRA-LOW VISION |
1R01EY028452-01 |
DAGNELIE, GISLIN |
NEI |
2017 |
|
INCIDENCE OF REMISSION AND OF CATARACT IN OCULAR INFLAMMATORY DISEASES |
1R21EY026717-01A1 |
KEMPEN, JOHN H |
NEI |
2017 |